文献速递乳腺介入US

超声引导真空辅助旋切处理乳腺穿刺后影像-病理不符病变

Ultrasound-guided vacuum-assisted excision: A minimally invasive solution for managing imaging-histological discordant breast lesions after core needle biopsy.
PubMed 文献 · Eur J Radiol · 2026-08-10

回顾性分析334例空芯针穿刺后影像-病理不符、接受9G超声引导真空辅助旋切的患者。旋切后升级为恶性率为9.3%,延迟假阴性率为1.3%,总体准确性98.2%,技术成功100%,无严重并发症。研究认为该技术可减少低估并避免不必要手术。

要点

  • 对CNB后影像-病理不符的乳腺病变,可用9G超声引导VAE进一步明确,恶性升级率约9.3%。
  • VAE诊断准确性高(98.2%)、特异度和PPV均达100%,但敏感度约88.6%,NPV 97.9%。
  • BI-RADS类别、形态、边缘和方位与恶性升级显著相关,阅片时应重点评估这些征象。

核心结论

  • 超声引导VAE可降低CNB后影像-病理不符病变合并恶性被低估的风险,提高诊断准确性,减少不必要手术。
  • 该技术在影像-病理不符乳腺病变管理中具有较高诊断价值,技术成功率100%,无严重并发症。

研究设计与样本

  • 回顾性研究,纳入2015年1月至2023年8月因CNB后影像-病理不符接受9G超声引导VAE的全部患者。
  • 共334例患者,中位年龄47.5岁(IQR 14);评估升级为恶性率、延迟假阴性、诊断效能、技术指标、并发症及相关因素。
  • 采用χ2检验和Mann-Whitney检验分析与恶性升级相关的病变特征及病史因素。

关键影像表现/征象

  • 乳腺病变的BI-RADS类别、形态、边缘和方位与VAE后升级为恶性显著相关(p<0.001)。

诊断标准与关键数值

  • VAE后总体恶性升级率为9.3%(31/334),B3病变占20.1%(67/334),良性占70.6%(236/334)。
  • 延迟假阴性率为1.3%;准确性98.2%[95%CI 0.95-0.99],敏感度88.6%[95%CI 0.73-0.97]。
  • 特异度100%[95%CI 0.98-1],阳性预测值100%[95%CI 0.89-1],阴性预测值97.9%[95%CI 0.95-0.99]。
  • 技术有效性(TE)为84.4%,技术成功率(TS)为100%,未见严重并发症。

临床应用与阅片要点

  • 对CNB后影像-病理不符的乳腺病变,超声引导VAE可作为避免不必要手术的微创处理选择。
  • 阅片时应重点关注BI-RADS类别、病变形态、边缘和方位,这些特征与恶性升级风险显著相关。
  • 即使VAE结果为良性,仍应结合延迟假阴性率约1.3%进行后续随访决策。

局限性

  • 回顾性单中心设计,可能存在选择偏倚;原文报告的技术有效性为84.4%,提示部分旋切可能不完全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the role of US-guided Vacuum-assisted excision (VAE) in the management of imaging-histological discordant lesions after core needle biopsy (CNB), avoiding unnecessary surgical excision.

MATERIALS AND METHODS: We retrospectively evaluated all patients who underwent US-guided VAE with a 9 G needle between January 2015 and August 2023 for imaging-histological discordance after CNB. We determined the upgrade rate to malignancy (UR) after VAE and delayed false-negative results after surgery or follow-up. We assessed the diagnostic performance of the procedure, technical efficacy (TE), technical success (TS), the occurrence of complications and the correlation between upgrade to malignancy and lesion size, BI-RADS category, morphological characteristics, presence of calcifications and history of breast cancer (χ2 and Mann-Whitney tests).

RESULTS: We collected data from 334 patients (median age 47.5 years, IQR 14). After VAE, 70.6 % (N = 236) of the excised lesions were benign, 20.1 % (N = 67) were B3 lesions and 9.3 % (N = 31) were malignant. The UR to malignancy was 9.3 %. The delayed false negative results were 1.3 %. Accuracy was 98.2 % [95 % CI: 0.95-0.99], SE was 88.6 % [95 % CI: 0.73-0.97], SP was 100 % [95 % CI: 0.98-1], PPV was 100 % [95 % CI: 0.89-1] and NPV was 97.9 % [95 % CI: 0.95-0.99]. TE was 84.4 %; TS was 100 %. No major complications were observed. BIRADS category, morphology, margins, and orientation of the lesion were significantly associated with upgrade to malignancy (p < 0.001).

CONCLUSIONS: VAE reduces the risk of underestimation of associated malignancy in imaging-histological discordant lesions and increases diagnostic accuracy, thus reducing the need for surgery, without compromising the quality of patient care.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Elisa, Catherine, Gianmarco, et al. Ultrasound-guided vacuum-assisted excision: A minimally invasive solution for managing imaging-histological discordant breast lesions after core needle biopsy. Eur J Radiol. 2026. PMID: 42585916. doi:10.1016/j.ejrad.2026.113160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。